TCG Crossover Management, LLC - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.

Quarter-by-quarter ownership
TCG Crossover Management, LLC ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$14,785,344
-20.4%
1,650,1500.0%2.18%
-28.5%
Q2 2023$18,564,188
-2.3%
1,650,1500.0%3.04%
-17.8%
Q1 2023$19,009,7281,650,1503.70%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,960,046$35,195,00013.16%
MPM ASSET MANAGEMENT LLC 4,951,303$58,871,00012.72%
Atlas Venture Life Science Advisors, LLC 8,934,902$106,236,0009.76%
Logos Global Management LP 3,234,392$38,457,0003.97%
GREAT POINT PARTNERS LLC 845,000$10,047,0002.23%
Deep Track Capital, LP 2,292,250$27,255,0001.92%
Octagon Capital Advisors LP 583,649$6,940,0001.35%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 476,000$5,641,0001.26%
COMMODORE CAPITAL LP 305,125$3,628,0000.84%
RA Capital Management 2,805,045$33,352,0000.59%
View complete list of DYNE THERAPEUTICS INC shareholders